GuideAI Health (FRA:ZN0) Ending Cash Position: €0.00 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:ZN0 GuideAI Health Corp FRA:ZN0
16 GF Score
Price €0.67
View Full Analysis

What is GuideAI Health Ending Cash Position?

GuideAI Health FRA:ZN0 +4.54% 16 Ending Cash Position is €0.00 Mil as of Mar. 2026. GuruFocus rates FRA:ZN0 with a GF Score™ of 16/100.

GuideAI Health's Ending Cash Position for the quarter that ended in Mar. 2026 was €0.00 Mil.

GuideAI Health's annual Ending Cash Position increased from Jun. 2023 (€0.00 Mil) to Jun. 2024 (€0.15 Mil) but then declined from Jun. 2024 (€0.15 Mil) to Jun. 2025 (€0.02 Mil).

GuideAI Health Ending Cash Position Related Terms

GuideAI Health Ending Cash Position Historical Data

* Premium members only.

The historical data trend for GuideAI Health's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GuideAI Health Ending Cash Position Chart

GuideAI Health Annual Data
Trend Jun23 Jun24 Jun25
Ending Cash Position
0.00 0.15 0.02

GuideAI Health Quarterly Data
Jun23 Jun24 Mar25 Jun25 Mar26
Ending Cash Position 0.00 0.00 0.00 0.00 0.00
FRA:ZN0
16GF Score
GuideAI Health Corp FRA:ZN0
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GuideAI Health Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

GuideAI Health's Ending Cash Position for the fiscal year that ended in Jun. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=0.15+-0.126
=0.02

GuideAI Health's Ending Cash Position for the quarter that ended in Mar. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0+0
=0.00

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of €0.00 Mil mean?
GuideAI Health (FRA:ZN0) has a Ending Cash Position of €0.00 Mil as of Mar. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on GuideAI Health and its competitors.
Is GuideAI Health's Ending Cash Position too high?
GuideAI Health's current Ending Cash Position is €0.00 Mil. Overall, GuideAI Health has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does GuideAI Health's Ending Cash Position compare to VEEV and BTSG?
GuideAI Health's Ending Cash Position of €0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Healthcare Providers & Services company?
A good Ending Cash Position depends on the Healthcare Providers & Services industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on GuideAI Health and its competitors. GuideAI Health's current Ending Cash Position is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GuideAI Health stock overvalued right now?
GuideAI Health (FRA:ZN0) has a current Ending Cash Position of €0.00 Mil. The current Ending Cash Position is €0.00 Mil. GuideAI Health's overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For GuideAI Health (FRA:ZN0), the current Ending Cash Position is €0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

GuideAI Health Business Description

Other Exchanges GDAI:Canada
Address 550 Burrard Street, Suite 2300, Vancouver, BC, CAN, V6C 2B5
GuideAI Health Corp is a healthcare technology company using artificial intelligence to enable the early detection of vascular disease and support more precise treatment decisions. Its platform analyzes routine CT scans to identify peripheral vascular disease and other vascular conditions that are frequently missed or under-reported, generating structured, actionable reports for radiologists and treating clinicians. By surfacing disease earlier and matching findings to appropriate treatment pathways, it aims to improve patient outcomes while helping hospitals and radiology groups deliver more comprehensive vascular care. Its Platform Capabilities are AI-powered vascular imaging, Early detection of disease, subtle patterns and risk signals, Structured, consistent AI-generated, and Others.
16GF Score

Get the complete analysis for FRA:ZN0

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.67
Price